Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The applications of nanozymes in neurological diseases: From mechanism to design
Yuan Zhang, Lei Zhang, Man Wang, et al.
Theranostics (2023) Vol. 13, Iss. 8, pp. 2492-2514
Open Access | Times Cited: 22

Showing 22 citing articles:

Oxidative Stress in Health and Disease
V. Prakash Reddy
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2925-2925
Open Access | Times Cited: 97
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 44
Superoxide dismutase and neurological disorders
Saravana Babu Chidambaram, Nikhilesh Anand, Sudhir Varma, et al.
IBRO Neuroscience Reports (2024) Vol. 16, pp. 373-394
Open Access | Times Cited: 39
Lipidomics analysis of microalgal lipid production and heavy metal adsorption under glycine betaine-mediated alleviation of low-temperature stress
Xueting Song, Fanying Kong, Bing-Feng Liu, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 135831-135831
Closed Access | Times Cited: 38
Nanozyme enabled protective therapy for neurological diseases
F. C. Cheng, Sumasri Kotha, Miao Fu, et al.
Nano Today (2024) Vol. 54, pp. 102142-102142
Closed Access | Times Cited: 29
Biomedical potential of nanozymes: Harnessing redox enzyme mimicry for theranostic applications
Somaye Shahraki, Esmaeil Vaziri, Ali Akbar Saboury, et al.
Coordination Chemistry Reviews (2024) Vol. 517, pp. 215937-215937
Closed Access | Times Cited: 29
Neuromodulation by nanozymes and ultrasound during Alzheimer’s disease management
Viswanathan Karthika, Badrinathan Sridharan, Ji Won Nam, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
The Application of Nanovaccines in Autoimmune Diseases
Yuhong Tang, Lili Li
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 367-388
Open Access | Times Cited: 6
Ferroptosis: a new regulatory mechanism in neuropathic pain
Lu Li, Lingling Guo, Rui Gao, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 15
Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Edoardo Scarpa, Mariafrancesca Cascione, Anna Griego, et al.
Ibrain (2023) Vol. 9, Iss. 3, pp. 298-315
Open Access | Times Cited: 14
Nanozyme-assisted amplification-free CRISPR/Cas system realizes visual detection
Yuan Zhang, Wanpeng Yu, Man Wang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 11
Open Access | Times Cited: 4
Regulator of oxidative balance: Research progress of nanozymes in ROS-related diseases
Xiang Wang, Zidong Wang, Siyuan Hu, et al.
Materials Today Chemistry (2025) Vol. 44, pp. 102540-102540
Closed Access
Catalases: Role in Pollution Reduction Caused by Dyes
Aijaz Ali Otho, Sakib Hussain Laghari, Mujahid Mehdi, et al.
(2025), pp. 223-251
Closed Access
Nanozymes in biomedicine: Unraveling trends, research foci, and future trajectories via bibliometric insights (from 2007 to 2024)
Siyang Cao, Yingchen Pang, Yihao Wei, et al.
International Journal of Biological Macromolecules (2025), pp. 142798-142798
Closed Access
Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases
Carmen Duță, Carmen Beatrice Dogaru, Corina Muscurel, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3522-3522
Open Access
Prospecting Carbon-Based Nanomaterials for Harnessing Multienzyme-Like Activities
Iqra Batool, Ayesha Anwar, Muhammad Imran, et al.
Topics in Catalysis (2024)
Closed Access | Times Cited: 3
Crosstalk between ubiquitin ligases and ncRNAs drives cardiovascular disease progression
Jiarui You, Zeng-Jin Wen, Jiawei Tian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Recent advances in nanoenzymes for Alzheimer's disease treatment
Xiaojun Bi, Ning Cao, Jingteng He
Colloids and Surfaces B Biointerfaces (2024) Vol. 244, pp. 114139-114139
Closed Access | Times Cited: 3
Novel application of nanomedicine for the treatment of acute lung injury: a literature review
Xianfeng Chen, Zhanhong Tang
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access | Times Cited: 2
Single-atom nanozyme liposome-integrated microneedles for in situ drug delivery and anti-inflammatory therapy in Parkinson’s disease
Ying Liu, Ye Liu, Peng Shi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: recent insights and potential clinical applications
Mehrdad Hashemi, Asal Abolghasemi Fard, Bita Pakshad, et al.
Non-coding RNA Research (2024) Vol. 11, pp. 1-21
Open Access | Times Cited: 1
Application of engineered antibodies (scFvs and nanobodies) targeting pathological protein aggregates in Alzheimer’s disease
Yuan Zhang, Wanpeng Yu, Lei Zhang, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 10, pp. 1047-1062
Closed Access
Page 1

Scroll to top